Personal information

Activities

Collapse all

Employment (1)

Genentech Inc: South San Francisco, CA, US

2016-11-10 to present (Clinical Pharmacology)
Employment
Source: Self-asserted source
Rucha Sane

Works (2)

Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib.

Cancer chemotherapy and pharmacology
2021-09-01 | Journal article
DOI: 10.1007/s00280-021-04344-9
PMID: 34471960
Source: Self-asserted source
Rucha Sane

Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using Two Methods of Classification of Hepatic Function.

Journal of clinical pharmacology
2021-08-16 | Journal article
DOI: 10.1002/jcph.1941
PMID: 34402068
Source: Self-asserted source
Rucha Sane
How many people are using ORCID?